Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

  • Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Market Research Reports > Pharmaceutical > Neurodegenerative Disease
Search for Annual Information Service
Browse by Region

Neurodegenerative Disease Market Research Reports

We offer reports covering rare and common neurodegenerative diseases such as MS, dementia, Alzheimer’s, and epilepsy. Central nervous system drugs are covered individually in the research, which contains information regarding drug pipelines and R&D challenges, as well as assessments of market potential.

Filter
Title Search
1 - 25 of 489 Products Sort by Display
Medulloblastoma - Global Clinical Trials Review, H2, 2021
Medulloblastoma - Global Clinical Trials Review, H2, 2021
Published by
GlobalData
Product code
1019764
Published
July 15, 2021
Content info
170 Pages
Price
USD 2500
Sample available
Global Duchenne Muscular Dystrophy Treatment Market - 2021-2028
Global Duchenne Muscular Dystrophy Treatment Market - 2021-2028
Published by
DataM Intelligence
Product code
1018763
Published
July 15, 2021
Content info
180 Pages
Price
USD 4350
Sample available
Global Antiepileptic Drugs Market - 2021-2028
Global Antiepileptic Drugs Market - 2021-2028
Published by
DataM Intelligence
Product code
972288
Published
July 7, 2021
Content info
180 Pages
Price
USD 4350
Sample available
Parkinson's Disease - Epidemiology Forecast to 2030
Parkinson's Disease - Epidemiology Forecast to 2030
Published by
DelveInsight Business Research LLP
Product code
1018501
Published
Pre-Order
Content info
120 Pages
Price
USD 5100
Sample available
Parkinson's Disease- Market Insight, Epidemiology and Market Forecast -2030
Parkinson's Disease- Market Insight, Epidemiology and Market Forecast -2030
Published by
DelveInsight Business Research LLP
Product code
1018491
Published
Pre-Order
Content info
248 Pages
Price
USD 8500
Sample available
*
U.S. Behavioral Health Care Software And Services Market Size, Share & Trends Analysis Report By Component (Software, Support Services), By Delivery Model, By Function, By End Use, And Segment Forecasts, 2021 - 2028
Published by
Grand View Research, Inc.
Product code
1019746
Published
June 30, 2021
Content info
80 Pages
Price
USD 5950
Sample available
Spinal Muscular Atrophy (SMA) (Central Nervous System) - Drugs In Development, 2021
Spinal Muscular Atrophy (SMA) (Central Nervous System) - Drugs In Development, 2021
Published by
Global Markets Direct
Product code
1017662
Published
June 30, 2021
Content info
186 Pages
Price
USD 2000
Sample available
Trigeminal Neuralgia (Tic Douloureux) (Central Nervous System) - Drugs In Development, 2021
Trigeminal Neuralgia (Tic Douloureux) (Central Nervous System) - Drugs In Development, 2021
Published by
Global Markets Direct
Product code
1017660
Published
June 30, 2021
Content info
80 Pages
Price
USD 2000
Sample available
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Central Nervous System) - Drugs In Development, 2021
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Central Nervous System) - Drugs In Development, 2021
Published by
Global Markets Direct
Product code
1017659
Published
June 30, 2021
Content info
96 Pages
Price
USD 2000
Sample available
Alzheimer's Disease (Central Nervous System) - Drugs In Development, 2021
Alzheimer's Disease (Central Nervous System) - Drugs In Development, 2021
Published by
Global Markets Direct
Product code
1017657
Published
June 30, 2021
Content info
2055 Pages
Price
USD 2500
Sample available
Epilepsy (Central Nervous System) - Drugs In Development, 2021
Epilepsy (Central Nervous System) - Drugs In Development, 2021
Published by
Global Markets Direct
Product code
1017656
Published
June 30, 2021
Content info
789 Pages
Price
USD 2500
Sample available
Dementia (Central Nervous System) - Drugs In Development, 2021
Dementia (Central Nervous System) - Drugs In Development, 2021
Published by
Global Markets Direct
Product code
1017655
Published
June 30, 2021
Content info
682 Pages
Price
USD 2500
Sample available
Encephalomyelitis (Central Nervous System) - Drugs In Development, 2021
Encephalomyelitis (Central Nervous System) - Drugs In Development, 2021
Published by
Global Markets Direct
Product code
1017654
Published
June 30, 2021
Content info
69 Pages
Price
USD 2000
Sample available
*
Global Pregabalin Market - 2021-2028
Published by
DataM Intelligence
Product code
1017201
Published
June 30, 2021
Content info
180 Pages
Price
USD 4350
Sample available
Global Ischemic Optic Neuropathy Treatment Market Size study, by Treatment Type (Steroidal Therapy, Immunomodulators therapy, Other Treatment Types), and Regional Forecasts 2021-2027
Global Ischemic Optic Neuropathy Treatment Market Size study, by Treatment Type (Steroidal Therapy, Immunomodulators therapy, Other Treatment Types), and Regional Forecasts 2021-2027
Published by
Bizwit Research & Consulting LLP
Product code
1016989
Published
June 23, 2021
Content info
Price
USD 4950
Sample available
*
Bipolar Depression - Epidemiology Forecast to 2030
Published by
DelveInsight Business Research LLP
Product code
1009783
Published
Pre-Order
Content info
120 Pages
Price
USD 3750
Sample available
*
Bipolar Depression - Market Insight, Epidemiology and Market Forecast -2030
Published by
DelveInsight Business Research LLP
Product code
1009776
Published
Pre-Order
Content info
240 Pages
Price
USD 6950
Sample available
*
Spinal Muscular Atrophy Treatment Market Research Report by Type, by Treatment, by Route of Administration, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
Published by
360iResearch LLP
Product code
1005113
Published
June 1, 2021
Content info
191 Pages
Price
USD 3949
Sample available
*
Behavioral Health Care Software & Services Market Research Report by Component, by Delivery Model, by Function, by End-user, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
Published by
360iResearch LLP
Product code
1000990
Published
June 1, 2021
Content info
181 Pages
Price
USD 3949
Sample available
*
Amyotrophic Lateral Sclerosis Treatment Market Research Report by Treatment, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
Published by
360iResearch LLP
Product code
995414
Published
June 1, 2021
Content info
198 Pages
Price
USD 3949
Sample available
*
Alzheimer's Therapeutics Market Research Report by Diagnostics, by Therapeutics, by Drug Class, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
Published by
360iResearch LLP
Product code
995366
Published
June 1, 2021
Content info
187 Pages
Price
USD 3949
Sample available
*
South and Central America Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class, Route of Administration, and Distribution Channel
Published by
The Insight Partners
Product code
1018157
Published
May 28, 2021
Content info
119 Pages
Price
USD 3000
Sample available
*
North America Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class, Route of Administration, and Distribution Channel
Published by
The Insight Partners
Product code
1018110
Published
May 28, 2021
Content info
130 Pages
Price
USD 3000
Sample available
*
Middle East and Africa Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class, Route of Administration, and Distribution Channel
Published by
The Insight Partners
Product code
1018062
Published
May 28, 2021
Content info
128 Pages
Price
USD 3000
Sample available
*
Europe Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class, Route of Administration, and Distribution Channel
Published by
The Insight Partners
Product code
1018024
Published
May 28, 2021
Content info
143 Pages
Price
USD 3000
Sample available

About Contact User Guide Privacy Policy Terms and Conditions Site Map

© Copyright 1997-2021, Global Information, Inc. All rights reserved.